Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer
Gastric Cancer, Distal Gastrectomy
About this trial
This is an interventional treatment trial for Gastric Cancer focused on measuring Gastric Cancer, Distal gastrectomy, Reconstruction, Gastric adenocarcinoma, Roux-en-Y
Eligibility Criteria
Inclusion Criteria:
- Patients confirmed with gastric cancer
- Indicated for radical distal gastrectomy (cT1 to cT4a, any N, M0; according to AJCC/UICC 8th TNM staging for gastric cancer)
- Age from 18- to 80-year-old
- Agreed to participate in study with written inform consent
Exclusion Criteria:
- Pregnant patients
- An American Society of Anesthesiology (ASA) score of higher than 4
- Concurrent cancer or history of previous other cancers
- Previous gastrectomy
- Complications including bleeding, perforation required emergency gastrectomy
Sites / Locations
- University Medical Center Ho Chi Minh City
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Billroth-II modified
Roux-en-Y
An opening will be made at jejunum 25 cm from Treitz's ligament. Another at greater curvature of the stomach right above transected line. A straight stapling device will be used to make isoperistaltic anastomosis at posterior wall of the stomach. After checking for bleeding, common entry hole will be closed using running suture and 3 -5 sutures to attach afferent loop to the remnant stomach
Jejunum will be transected 25 to 30 cm from Treitz's ligament. Marginal vessels will be transected if needed to make sure the loop will reach the stomach without tension. Isoperistaltic gastrojejunostomy will be made at posterior wall of the stomach. After checking for bleeding, common entry hole will be closed using running suture. Jejunojejunal mesenteric defect and Petersen's defect will be closed.